Cryopep
French specialist in haemostasis and thrombosis diagnostics, supplying frozen and lyophilised reagents to clinical and research laboratories since 2008.
Last updated September 28, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Cryopep is a French company based in Montpellier that specialises in the diagnosis of haemostasis and thrombosis. Since 2008 it has supplied healthcare professionals, hospital and private biology laboratories, and research groups with frozen and lyophilised reagents designed for coagulation testing. Its catalogue is organised around three broad families: routine reagents, research reagents, and auxiliary or neutralising reagents. The routine range includes chromogenic Factor VIII and Factor IX assays marketed under the CRYOcheck™ name, pooled normal human plasma, and pools of plasma from healthy donors, including fresh plasma pools. These products are positioned as ready-to-use frozen reagents that can be adapted to many analysers, contain no additives, and avoid the reconstitution errors associated with lyophilised powders. The research range covers chromogenic substrates such as the activated Factor X (FXa) substrate pNAPEP-1025, Russell's viper venom in frozen form, and polyclonal antibodies including a sheep anti-human Factor VII antibody. The auxiliary range addresses interference in coagulation testing, with DOAC-Stop™ for neutralising direct oral anticoagulants and Antihepca™-HRRS for heparin neutralisation. Cryopep's stated priority is reliability, speed and precision of results. The company emphasises the quality of its human plasma pools, comparing them to plasma from healthy donors, and presents its frozen concept as an innovation for medical analysis laboratories. Its products are intended both for routine diagnostic workflows in haemostasis and thrombosis and for research projects that require well-characterised biological reagents. The company operates from Montpellier in southern France and serves laboratory customers in France and internationally. It is a private company and does not appear to be listed on a stock exchange. Its public identity is built around the idea of "cryogenics in the service of haemostasis", reflecting its focus on frozen reagent formats.
History
Cryopep was established in 2008 and is based in Montpellier, France. From its foundation, the company has focused on the diagnosis of haemostasis and thrombosis, building its activity around the supply of frozen and lyophilised reagents to healthcare professionals. Its stated mission is to provide high-quality reagents for hospital and private biology laboratories as well as for research projects. Over the years, Cryopep has developed a catalogue that spans routine coagulation testing, research reagents and auxiliary products. The routine range includes chromogenic Factor VIII and Factor IX assays under the CRYOcheck™ brand, pooled normal human plasma and pools of plasma from healthy donors, including fresh plasma pools. The research range includes chromogenic substrates such as the activated Factor X (FXa) substrate pNAPEP-1025, Russell's viper venom in frozen form and polyclonal antibodies such as a sheep anti-human Factor VII antibody. The auxiliary range addresses interference in coagulation testing, with DOAC-Stop™ for neutralising direct oral anticoagulants and Antihepca™-HRRS for heparin neutralisation. A central element of Cryopep's offering is its frozen reagent concept. The company presents these reagents as ready-to-use, adaptable to many analysers, free of additives and designed to avoid reconstitution errors, with the aim of delivering reliable, rapid and precise results. Cryopep also emphasises the quality of its human plasma pools, comparing them to plasma from healthy donors. The company operates from Montpellier and serves laboratory customers in France and internationally. It is a private company and does not appear to be listed on a stock exchange. Its public identity is built around the idea of "cryogenics in the service of haemostasis", reflecting its focus on frozen reagent formats.
- 2008
Cryopep is founded and begins specialising in haemostasis and thrombosis diagnostics.
Products and positioning
Specialist provider of high-quality frozen and lyophilised reagents for haemostasis and thrombosis diagnostics, targeting clinical biology laboratories and research projects with ready-to-use, additive-free products.
CRYOcheck™ Chromogenic Factor VIII
Chromogenic assay for Factor VIII, part of the routine reagent range.
CRYOcheck™ Chromogenic Factor IX
Chromogenic assay for Factor IX, part of the routine reagent range.
CRYOcheck™ Pooled Normal Plasma
Pooled normal human plasma for routine coagulation testing.
DOAC-Stop™
Auxiliary reagent for neutralising direct oral anticoagulants (DOACs) in coagulation testing.
Antihepca™-HRRS
Auxiliary reagent for heparin neutralisation.
pNAPEP-1025
Chromogenic substrate for activated Factor X (FXa), part of the research reagent range.
Russell's viper venom (frozen)
Frozen Russell's viper venom, a research reagent.
Anti-Factor VII polyclonal antibody
Sheep polyclonal antibody against human Factor VII, a research reagent.
Sources2 sources
Cite this profile: Cite the canonical profile. /brand-wiki/cryopep-france · Editorial policy · How profiles are compiled